Assignee profile:

MATTHIAS W. RATH

City:

APTOS, California

Country:

United States

Published Applications:

21

Last publication date:

2021-10-14

Patent Grants:

15

Last grant date:

2021-10-05

Top Inventors for applications by MATTHIAS W. RATH

These are the the leading inventors for applications assigned to MATTHIAS W. RATH:

Recent patent applications by MATTHIAS W. RATH

MATTHIAS W. RATH based in APTOS, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-10-14 ✅ Patent 11,135,196 granted on 2021-10-05
US20210315858A1
Human necessities

Pharmaceutical composition and its use to inhibit membrane ACE2 expression

#2 | 2021-10-14 ✅ Patent 11,419,847 granted on 2022-08-23
US20210315857A1
Human necessities

Pharmaceutical micronutrient composition and its use to simultaneously inhibit multiple cellular mechanisms of infectivity caused by coronavirus, its variants and mutants

#3 | 2020-08-11 ✅ Patent 10,736,872 granted on 2020-08-11
US16853519
Human necessities

Pharmaceutical mixture to treat statin induced vascular calcification

#4 | 2020-04-07 ✅ Patent 10,610,474 granted on 2020-04-07
US16584870
Human necessities

Antibacterial and antifungal dental health formulation

#5 | 2020-02-25 ✅ Patent 10,568,866 granted on 2020-02-25
US16152922
Human necessities

Composition and its use for increasing innate immune health

#6 | 2019-11-05 ✅ Patent 10,463,590 granted on 2019-11-05
US16226698
Human necessities

Antiplaque and dental health oral formulation

#7 | 2019-07-11 ✅ Patent 10,716,767 granted on 2020-07-21
US20190209489A1
Human necessities

Composition for eye health

#8 | 2019-03-26 ✅ Patent 10,238,619 granted on 2019-03-26
US15799573
Human necessities

Composition and method of using the same

#9 | 2017-12-07
US20170348280A1
Human necessities

COUNTERACTING THE INHIBITION OF COLLAGEN SYNTHESIS BY SELECT CALCIUM AND SODIUM CHANNEL BLOCKERS USING ASCORBIC ACID AND ASCORBYL PALMITATE

#10 | 2016-11-24
US20160339057A1
Human necessities

NOVEL COMPOSITION METHOD OF USING THE SAME FOR THE TREATMENT OF LYME DISEASE

#11 | 2016-04-21
US20160106777A1
Human necessities

NOVEL COMPOSITION METHOD OF USING THE SAME FOR THE TREATMENT OF LYME DISEASE

#12 | 2015-05-28 ✅ Patent 9,101,334 granted on 2015-08-11
US20150149217A1
Human necessities

Method and system for real time visualization of individual health condition on a mobile device

#13 | 2015-03-12 ✅ Patent 9,018,437 granted on 2015-04-28
US20150074837A1
Human necessities

Transgenic mouse expressing human apo(a) and human apo(B-100) with disabled vitamin C gene produces human Lp(a)

#14 | 2015-03-12
US20150074835A1
Human necessities

TRANSGENIC MOUSE EXPRESSING HUMAN LIPOPROTEIN (A) WITH DISABLED VITAMIN C GENE AND ITS USE AS A DISEASE TREATMENT MODEL

#15 | 2014-01-16
US20140017267A1
Chemistry; metallurgy

METALLOPROTEINASE OLIGOPEPTIDES AND THEIR THERAPEUTIC USE

#16 | 2014-01-16 ✅ Patent 10,968,441 granted on 2021-04-06
US20140017225A1
Human necessities

Metalloproteinase-9 oligopeptides and their therapeutic use

#17 | 2013-02-14 ✅ Patent 8,968,004 granted on 2015-03-03
US20130040273A1
Physics

Integrated multimedia tool system and method to explore and study the virtual human body

#18 | 2013-01-10
US20130011423A1
Chemistry; metallurgy

METALLOPROTEINASE OLIGOPEPTIDES AND THEIR THERAPEUTIC USE

#19 | 2011-11-29 ✅ Patent 8,067,009 granted on 2011-11-29
US13159941
-

Metalloproteinase oligopeptides and their therapeutic use

#20 | 2011-09-06 ✅ Patent 8,012,935 granted on 2011-09-06
US10350258
-

Synthetic peptides and methods for treating cancer invasion and metastasis

#21 | 2011-08-23 ✅ Patent 8,003,110 granted on 2011-08-23
US13012769
-

Metalloproteinase oligopeptides and their therapeutic use

Also check out Matthias W Rath's (Aptos, United States) applicant profile with 12 patent applications submitted.

AssigneeID:

3350 ⎘